Charles Schwab Corporation
SCHW
$89.47
+0.80%
The Charles Schwab Corporation is one of the largest US retail-oriented financial services firms, operating a vertically integrated platform spanning brokerage, banking (Charles Schwab Bank), asset management, RIA custody, and wealth advisory, with roughly $11.9 trillion in client assets at the end of 2025. Schwab is a scale-driven platform incumbent rather than a disruptor: it dominates Registered Investment Advisor custody with over 40% market share and monetizes client cash through its bank, making net interest income and asset gathering the twin engines of earnings. The current investor debate centers on a powerful earnings recovery — Q2 2026 revenue of $8.52 billion grew 24.97% year over year on record revenue and strong client asset inflows — set against a stock that has badly lagged the market, down roughly 4% over twelve months versus a 13% gain for the S&P 500. Bulls point to AI-driven operating efficiency, a re-steepening rate environment following the Fed's first hike since 2023, and a forward P/E near 11.6x; bears focus on the sharp September-October drawdown, cash-sorting and client-cash-mix dynamics, and competitive pressure from faster-growing platforms like Robinhood and Interactive Brokers.…
SCHW
Charles Schwab Corporation
$89.47
Related headlines
Investment Opinion: Should I buy SCHW Today?
Rating: Buy (accumulate on weakness). The core thesis is that Schwab is a scaled, 43%-operating-margin franchise trading at 11.60x forward earnings — a discount that already prices in skepticism about its earnings recovery — while 22 analysts carry a buy consensus (mean 1.83) and a $117.59 average target implying 29.8% upside from $90.58. The stock's 17.38-point one-year underperformance versus SPY has created an asymmetric setup for investors willing to look through the technical downtrend.
Supporting evidence is concrete: Q2 2026 revenue grew 24.97% year over year to $8.518 billion, net margin expanded from 21.49% in Q3 2024 to 32.87%, and operating margin reached 43.07%. Free cash flow TTM of $3.705 billion funded $3.054 billion of buybacks and $643 million of dividends in Q2 2026 alone, and the 0.38 PEG is among the lowest in Financial - Capital Markets. The 11.60x forward PE versus 21.35x trailing and 3.58x price-to-book versus a 2.51x-4.24x recent range show the market is paying for undelivered earnings, not current profitability.
Key risks that could invalidate the thesis are a stall in the $11.50 forward EPS recovery, continued client cash sorting, and competitive share loss to Robinhood and Interactive Brokers. The rating would upgrade to a stronger Buy if the stock reclaims the $97-$100 breakdown zone or forward EPS estimates rise above $12.00; it would downgrade to Hold if revenue growth decelerates below 15% or the stock breaks below the $83.96 52-week low. Verdict: undervalued relative to its own history and growth rate, though fairly valued on a mid-cycle earnings basis — the discount is an opportunity only if the recovery holds.
Sign up to view all
SCHW 12-Month Price Forecast
The forward-looking view is constructive but not without caveats: Schwab's fundamentals are accelerating while its stock has de-rated to 11.60x forward earnings, a gap that historically resolves in the stock's favor when earnings hold. The 29.8% implied upside to the $117.59 average target and the 0.38 PEG anchor the bull case, while the 7.3% downside to the $83.96 52-week low bounds the bear case. Confidence is medium because the technical downtrend is unresolved and the forward EPS step-up is unproven. I would upgrade to high confidence if the stock reclaims $97-$100 or Q3 2026 EPS exceeds $1.60, and downgrade to neutral if revenue growth falls below 15% or the stock breaks $83.96.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Charles Schwab Corporation's 12-month outlook, with a consensus price target around $117.32 and implied upside of +31.1% versus the current price.
Average Target
$117.32
0 analysts
Implied Upside
+31.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$82 - $147
Analyst target range
Coverage is deep and constructive: 22 analysts follow SCHW with a consensus recommendation of "buy" (mean rating 1.83 on a 1-5 scale where 1 is strong buy), and the average target price of $117.59 implies roughly 29.8% upside from the current $90.58. The consensus is clearly bullish — the average target sits near the top of the 52-week range — and the recent institutional ratings flow supports that stance, with Morgan Stanley, Barclays, and UBS reiterating Overweight/Buy ratings in July 2026 and Argus and Raymond James maintaining Buy/Outperform. The one notable crack is BMO Capital's July 20 downgrade from Outperform to Market Perform, suggesting at least one house sees the risk/reward as less compelling after the summer rally.
The target range of $82.00 to $147.00 is very wide — a 79% spread from low to high — which signals genuine disagreement about the earnings trajectory rather than a lack of coverage. The $147 high target likely assumes the forward EPS of $11.50 is achieved with multiple expansion toward the mid-teens, driven by AI-driven efficiency gains, continued asset inflows, and a favorable rate backdrop; the $82 low target, below the current price, prices in margin compression, a reversal in client cash trends, or competitive share loss to lower-cost platforms. Consensus revenue of $40.68 billion (range $38.32-$42.05 billion) and EPS of $11.50 (range $10.63-$12.00) frame the debate, and the tight EPS range relative to the wide price targets indicates the dispersion is about valuation multiple, not fundamentals — a setup where the stock's 29.8% implied upside is credible but dependent on the market re-rating a name that has underperformed SPY by 17 points over the past year.
Drowning in data?
Find the real signal!
Bulls vs Bears: SCHW Investment Factors
The bear case currently has stronger near-term evidence: SCHW has underperformed SPY by 17.38 points over one year and 22.27 points YTD, sits just 21.6% up its 52-week range, and has broken down technically after a failed August breakout. Yet the fundamental data is genuinely strong — 24.97% revenue growth, 43.07% operating margin, and a 0.38 PEG — and the 11.60x forward PE versus 21.35x trailing suggests the market has already priced substantial skepticism. The single most important tension is whether the consensus $11.50 forward EPS materializes: if it does, the stock is cheap and the 29.8% analyst upside is credible; if the earnings recovery stalls, the multiple has further to compress. Until the stock reclaims the $97-$100 breakdown zone, the technical and relative-strength evidence favors the bears, but the valuation and analyst consensus tilt the risk/reward toward patient buyers.
Bullish
- Earnings recovery accelerating: Q2 2026 revenue of $8.518 billion grew 24.97% year over year, and net income rose from $1.408 billion in Q3 2024 to $2.80 billion in Q2 2026. EPS more than doubled from $0.71 to $1.55 over the same span, showing the cash-sorting drag has fully unwound.
- Deeply discounted forward multiple: At 11.60x forward EPS of $11.50 versus 21.35x trailing, the stock trades at a steep discount to its own history (14.9x-33.7x) and a PEG of 0.38. The market is pricing the recovery as temporary, leaving room for multiple expansion if earnings hold.
- Analyst consensus sees 30% upside: 22 analysts rate SCHW a buy (mean 1.83), with an average target of $117.59 implying 29.8% upside from $90.58. Morgan Stanley, Barclays, and UBS reiterated Overweight/Buy in July 2026, and the high target of $147 sits 62% above the current price.
- Top-tier margins and capital returns: Operating margin of 43.07% and net margin of 32.87% are best-in-class for a capital-markets platform. Schwab returned $3.054 billion in buybacks and $643 million in dividends in Q2 2026 alone, with a 26.3% payout ratio leaving ample room.
Bearish
- Severe relative underperformance: SCHW is down 4.25% over one year versus SPY's 13.13% gain, a 17.38-point relative shortfall, and down 10.82% YTD versus SPY's 11.45% gain (22.27-point gap). The stock sits only 21.6% up its 52-week range, signaling persistent de-rating.
- Failed breakout and downtrend: After rallying to $113.65 on August 24, the stock rolled over and fell 8.96% in the past month versus SPY's 1.02% decline. The abrupt October slide from $97.06 to $89.58 confirms lower highs, with support at the $83.96 52-week low only 7.3% below.
- Forward EPS step-up is unproven: The 11.6x forward PE assumes EPS rises roughly 46% to $11.50 from the current run-rate, a demanding bar. If the earnings recovery stalls, the stock would re-rate toward the trailing multiple, implying meaningful downside from $90.58.
- Competitive share loss risk: Robinhood now runs 13 revenue lines above $100 million annually and Interactive Brokers grew customer accounts 34% in a year, pressuring Schwab's retail franchise. BMO Capital downgraded SCHW to Market Perform on July 20, 2026, citing less compelling risk/reward.
SCHW Technical Analysis
SCHW is in a corrective downtrend within a broader range, with the stock down 4.25% over the past year, 10.82% year to date, and trading at $90.58 — only about 21.6% of the way up its 52-week range of $83.96 to $114.53. That positioning near the lower third of the annual range signals a market that has de-rated the shares rather than rewarded momentum; the stock is closer to a value-opportunity zone than an overextension zone, but the persistent lower highs argue against calling a bottom prematurely. Relative strength confirms the underperformance: SCHW trails SPY by 17.38 percentage points over one year and 22.27 points year to date, a meaningful divergence from a benchmark that has been making progress.
Short-term momentum has deteriorated sharply and is diverging negatively from the already-weak longer-term trend. The stock is down 8.96% over the past month and 11.17% over three months, versus a 1.02% decline and 2.85% gain for SPY over the same windows, producing relative strength readings of -7.94 and -14.02 points respectively. The 6-month change of +2.35% shows the stock did rally hard into the summer — peaking near $113.65 on August 24 — before rolling over, so the recent weakness looks like a failed breakout and trend reversal rather than a simple mean-reversion pullback; the October slide from $97.06 on October 12 to $89.58 on October 19 was particularly abrupt, and the modest bounce to $90.58 has not reclaimed any meaningful level.
Key technical levels are well defined: support sits at the 52-week low of $83.96, roughly 7.3% below the current $90.58, while resistance is anchored at the 52-week high of $114.53, about 26.4% above. A decisive break below $83.96 would confirm the downtrend and likely trigger further de-risking, whereas reclaiming the $97-$100 area (the October breakdown zone) would be the first sign of stabilization, with a move through $114.53 required to reassert the longer-term uptrend. Volatility is comparatively contained — beta of 0.782 means the stock should move roughly 22% less than the market — but the max drawdown of -21.18% shows that low beta has not insulated holders from a meaningful peak-to-trough decline, and the 6.99 million share volume with a 2.28 short ratio suggests no aggressive short crowding either way.
Beta
0.78
0.78x market volatility
Max Drawdown
-21.9%
Largest decline past year
52-Week Range
$84-$115
Price range past year
Annual Return
-5.4%
Cumulative gain past year
| Period | SCHW Return | S&P 500 |
|---|---|---|
| 1m | -9.7% | +0.7% |
| 3m | -15.0% | +3.0% |
| 6m | -2.3% | +6.8% |
| 1y | -5.4% | +11.9% |
| ytd | -11.9% | +12.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SCHW Fundamental Analysis
Revenue is on a clear accelerating trajectory. Q2 2026 revenue of $8.518 billion grew 24.97% year over year versus $6.816 billion in Q2 2025, and the sequential path has been consistently upward: $7.041 billion in Q3 2025, $7.168 billion in Q4 2025, $7.300 billion in Q1 2026, and $8.518 billion in Q2 2026. Segment data shows Investor Services at $9.919 billion and Advisor Services at $2.552 billion, with the retail/brokerage side the larger revenue base while RIA custody provides the stickier, higher-multiple growth engine. The growth trend — reinforced by record revenue and strong asset inflows per recent coverage — supports the bull case that Schwab is compounding client assets and monetizing them more effectively as rate conditions normalize.
Profitability is robust and improving. Q2 2026 net income was $2.80 billion on a 32.87% net margin, with gross margin of 83.02% and operating margin of 43.07%; net income has risen every quarter from $1.408 billion in Q3 2024 to $2.80 billion in Q2 2026, and EPS climbed from $0.71 to $1.55 over the same span. The margin trajectory is the key story: net margin expanded from 21.49% in Q3 2024 to 32.87% in Q2 2026, and operating margin from 28.11% to 43.07%, reflecting both operating leverage and the unwind of the client cash-sorting drag. For a capital-markets/brokerage business, a 43% operating margin and 32%+ net margin are top-tier, consistent with Schwab's scale advantages in custody and banking.
Balance sheet and cash flow require nuance. Debt-to-equity is a manageable 0.626 with a current ratio of 0.530 — low, but typical for a bank-heavy model where deposits and client payables dominate the liability side — while ROE of 17.91% and ROA of 2.16% are healthy for a financial. Free cash flow TTM is $3.705 billion, but quarterly operating cash flow is highly volatile (-$2.784 billion in Q2 2026, +$7.342 billion in Q1 2026, -$0.763 billion in Q4 2025) because client cash movements and securities maturities swing working capital; the company returned capital aggressively with $3.054 billion of buybacks and $643 million of dividends in Q2 2026 alone. The dividend yield of 1.32% with a 26.3% payout ratio leaves ample room, and the PEG of 0.38 suggests cash generation is more than sufficient to fund growth internally despite the noisy quarterly FCF prints.
Quarterly Revenue
$8.5B
2026-06
Revenue YoY Growth
+25.0%
YoY Comparison
Gross Margin
83.0%
Latest Quarter
Free Cash Flow
$3.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SCHW Overvalued?
Because net income is positive ($2.80 billion in Q2 2026), the PE ratio is the primary metric. SCHW trades at 21.35x trailing earnings but only 11.60x forward earnings (on consensus EPS of $11.50), an unusually wide gap that implies the market expects a substantial earnings step-up — roughly a 46% increase in EPS — over the next twelve months. That forward multiple is the crux of the valuation debate: at 11.6x forward, the stock is priced as if the current earnings recovery is either temporary or at risk, which is a notably pessimistic stance for a franchise with 43% operating margins.
Against the Financial - Capital Markets industry, the picture is mixed. The 21.35x trailing PE and 3.58x price-to-book sit at a premium to traditional brokerage peers, but the 6.40x price-to-sales and 4.79x EV/sales are elevated because Schwab's revenue base includes low-multiple interest income; the more telling comparison is the 12.63x EV/EBITDA, which is reasonable for a scaled financial platform. The 0.38 PEG ratio is the standout — it implies the stock is cheap relative to its growth rate, and the 11.6x forward PE versus a 21.3x trailing PE suggests the premium is being paid for earnings that have not yet been delivered rather than for current profitability.
Historically, SCHW's PE has ranged from roughly 14.9x (Q2 2026) to 33.7x (Q4 2023), with the trailing multiple now at 21.35x — near the middle of that band but well below the 2023-2024 peaks. The price-to-book of 3.58x is near the top of its recent range (2.51x in Q3 2024 to 4.24x in Q4 2022), while the price-to-sales of 6.40x is far below the 18-25x readings of 2024-2025, reflecting the revenue base expansion. The market is therefore pricing SCHW at a mid-cycle earnings multiple with a below-average sales multiple — a setup that offers upside if the forward EPS estimate of $11.50 materializes, but leaves little cushion if the earnings recovery stalls.
PE
21.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 15x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the bank-heavy model and earnings dependence. Schwab's current ratio of 0.530 and debt-to-equity of 0.626 reflect a balance sheet dominated by client payables and deposits, making net interest income highly sensitive to rate and cash-mix shifts. Quarterly operating cash flow is erratic — -$2.784 billion in Q2 2026 versus +$7.342 billion in Q1 2026 — because client cash movements and securities maturities swing working capital, so reported FCF of $3.705 billion TTM can mask liquidity strain. The 11.60x forward PE also embeds a roughly 46% EPS step-up to $11.50; any shortfall in asset gathering or net interest margin would force a re-rating toward the 21.35x trailing multiple's implied earnings base, compressing the stock.
Market and competitive risks are elevated by the stock's persistent de-rating and faster-growing rivals. SCHW trades at 3.58x book and 6.40x sales, a premium to traditional brokers, while trailing SPY by 17.38 points over one year and 22.27 points YTD — a divergence that can persist if sector rotation favors growth platforms. Robinhood's 13 revenue lines above $100 million and Interactive Brokers' 34% account growth underscore share-loss risk in retail brokerage, and BMO's July 2026 downgrade to Market Perform signals cracks in the bullish consensus. Beta of 0.782 offers some downside cushion, but the Fed's first hike since 2023 raises the risk that higher rates pressure client cash allocations and equity multiples simultaneously.
Worst-case scenario: a stall in the earnings recovery combines with continued client cash sorting and competitive share loss, pushing EPS below the $10.63 low estimate and forcing the multiple toward the low end of its historical range. In that chain, the stock would retest the 52-week low of $83.96, roughly 7.3% below the current $90.58, and a decisive break could extend toward the $82 analyst low target, about 9.5% downside. A fuller de-rating toward the 2024-2025 sales multiple lows, or a repeat of the -21.18% max drawdown from the $113.65 August peak, would imply a loss of roughly 21% from current levels — the realistic adverse outcome for holders.
FAQ
The most severe risk is earnings risk: the 11.60x forward PE assumes EPS rises roughly 46% to $11.50, and any shortfall would force a re-rating toward the 21.35x trailing multiple. Second is competitive risk, with Robinhood's 13 revenue lines above $100 million and Interactive Brokers' 34% account growth pressuring Schwab's retail franchise, underscored by BMO's July 2026 downgrade. Third is financial/liquidity risk from the bank-heavy model, where quarterly operating cash flow swung from +$7.342 billion to -$2.784 billion and the current ratio is 0.530. Fourth is macro and rate risk: the Fed's September 2026 hike could pressure client cash allocations and equity multiples simultaneously, though beta of 0.782 offers some cushion.
The 12-month forecast has three scenarios: a 30% probability bull case targeting $117.59-$147.00 if forward EPS of $11.50 materializes with multiple expansion, a 50% probability base case targeting $95.00-$117.59 as earnings are delivered but the multiple stays near 11-13x, and a 20% probability bear case targeting $82.00-$83.96 if the recovery stalls and the stock retests its 52-week low. The base case is most likely, resting on the assumption that consensus revenue of $40.68 billion and EPS of $11.50 are achieved while operating margin holds above 40%. The wide $82-$147 analyst target range reflects genuine disagreement about the earnings trajectory rather than a lack of coverage.
SCHW looks undervalued on forward earnings but fairly valued on trailing metrics. The 11.60x forward PE is well below the 21.35x trailing multiple and the 14.9x-33.7x historical range, while the 0.38 PEG is among the lowest in Financial - Capital Markets. The 3.58x price-to-book sits near the top of its 2.51x-4.24x recent range, and the 6.40x price-to-sales is far below the 18-25x readings of 2024-2025, reflecting the expanded revenue base. The market is paying a mid-cycle earnings multiple with a below-average sales multiple, implying it expects the current earnings recovery to be temporary rather than durable. If the $11.50 forward EPS materializes, the stock is cheap; if it stalls, the valuation offers little cushion.
From a risk/reward perspective, SCHW offers roughly 29.8% upside to the $117.59 analyst average target against about 7.3% downside to the $83.96 52-week low, a favorable asymmetry for investors with a 12-18 month horizon. The 11.60x forward PE and 0.38 PEG suggest the market has already priced substantial skepticism into a franchise growing revenue 24.97% year over year. The biggest downside risk is that the $11.50 forward EPS estimate proves too optimistic, forcing a re-rating toward the 21.35x trailing multiple's implied earnings base. It is a good buy for value-oriented investors comfortable with near-term technical weakness, but momentum traders should wait for a reclaim of the $97-$100 breakdown zone before committing capital.
SCHW is better suited to long-term holding than short-term trading. The stock is in a corrective downtrend — down 8.96% in the past month and 11.17% over three months — with a failed August breakout at $113.65, so near-term momentum is unfavorable for traders. Beta of 0.782 and a 1.32% dividend yield with a 26.3% payout ratio support a patient, income-oriented approach, while the 0.38 PEG and 11.60x forward PE reward a 12-18 month horizon that allows the earnings recovery to be validated. A concrete minimum holding period of 12 months aligns with the consensus EPS estimate cycle and the analyst target horizon. Short-term traders should wait for a reclaim of $97-$100 before entering.